MEDTOX Scientific (Nasdaq:MTOX), reported today that it had entered into a definitive merger agreement with Laboratory Corporation of America(R) Holdings (NYSE:LH). Under the terms of the agreement, LabCorp would acquire MEDTOX for a purchase price of $27.00 per share in cash, representing a total enterprise value of approximately $241,000,000.
MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a
provider of high quality specialized laboratory testing services and
on-site/point-of-collection testing (POCT) devices. The Company also
supports customers with complete logistics, data
and program management services. MEDTOX is a leader in providing
esoteric laboratory testing services to hospitals and laboratories
nationwide. This includes both central laboratory and bio-analytical
testing for pharmaceutical clinical trials. MEDTOX develops and
manufactures diagnostic devices for quick and economical
on-site/point-of-collection analysis for drugs-of-abuse and therapeutic
drugs, and provides employment drug screening and occupational health
testing. For more information see www.medtox.com.About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts at Investor Ideas
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research tech stocks, oil and gas stocks, gold stocks, water stocks, renewable energy stocks and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
No comments:
Post a Comment